Tsuchimoto, Akihiro
,
Masutani, Kosuke
Omoto, Kazuya
Okumi, Masayoshi
Okabe, Yasuhiro
Nishiki, Takehiro
Ota, Morihito
Nakano, Toshiaki
Tsuruya, Kazuhiko
Kitazono, Takanari
Nakamura, Masafumi
Ishida, Hideki
Tanabe, Kazunari
Funding for this research was provided by:
Astellas Pharma
Article History
Received: 8 June 2018
Accepted: 13 November 2018
First Online: 24 December 2018
Compliance with ethical standards
:
: Potential financial conflicts of interest: Astellas Pharma Inc. (Tokyo, Japan) supported this study and Kazunari Tanabe with a grant. The sponsor was not involved in the study design, patient enrolment, data collection, analysis, interpretation, or preparation of the manuscript.
: All procedures performed in studies involving human participants were in accordance with the ethical standards of the institutional and/or national research committee at which the studies were conducted (IRB approval number UMIN000018327) and with the 1964 Helsinki declaration and its later amendments or comparable ethical standards.
: Written informed consent was obtained from all individual participants included in the study.